Galectin Therapeutics Inc. (GALT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.87M | -6.04M | -3.54M | -6.6M | -7.69M | -12.79M | -8.54M | -8.33M | -12.11M | -4.7M | -7.64M | -9.83M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 49.72% | 52.76% | 58.51% | 20.77% | 36.48% | -172.03% | -11.8% | 15.25% | -12.16% | 35.05% | 8.51% | -32.38% |
| Net Income | -5.05M | -5.5M | -8.18M | -7.52M | -9.63M | -11.97M | -11.22M | -12.37M | -11.49M | -10M | -10.43M | -9.11M |
| Depreciation & Amortization | 12K | 41K | 0 | 2K | 10K | 10K | 9K | 9K | 9K | 9K | 8K | 0 |
| Stock-Based Compensation | 686K | 195K | 496K | 500K | 468K | 590K | 515K | 738K | 604K | 497K | 586K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -827K | 403K | 2.42M | 1.45M | 372K | -1.75M | 1.04M | 141K | 1.08M | -145K | 682K | 179K |
| Working Capital Changes | 1.31M | -1.18M | 1.73M | -1.03M | 1.09M | 326K | 1.11M | 3.15M | -2.31M | 4.93M | 1.51M | -898K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -662K | -2.46M | -345K | -2.72M | -522K | -521K | -173K | 1.91M | -3.29M | 5.08M | 621K | -1.66M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 257K | 12.24M | 1.3M | 12.94M | 0 | 851K | 10M | 10.38M | 10M | 10M | 10.03M | 10M |
| Debt Issued (Net) | 0 | 10M | 0 | 11M | 0 | 0 | 10M | 10M | 10M | -20M | 0 | 10M |
| Equity Issued (Net) | 257K | 2.24M | 853K | 1.94M | 0 | 851K | 0 | 376K | 0 | 30M | 10.03M | 0 |
| Dividends Paid | -61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 61K | 0 | 443K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -3.61M | 6.2M | -2.25M | 6.34M | -7.69M | -11.94M | 1.46M | 2.04M | -2.1M | 5.3M | 2.4M | 167K |
| Free Cash Flow | -3.87M | -6.04M | -3.54M | -6.6M | -7.69M | -12.79M | -8.54M | -8.33M | -12.11M | -4.7M | -7.64M | -9.83M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 49.72% | 52.76% | 58.51% | 20.77% | 36.48% | -172.03% | -11.8% | 15.25% | -12.16% | 35.05% | 8.51% | -32.38% |
| FCF per Share | -0.06 | -0.09 | -0.06 | -0.10 | -0.12 | -0.20 | -0.14 | -0.13 | -0.20 | -0.08 | -0.13 | -0.17 |
| FCF Conversion (FCF/Net Income) | 0.77x | 1.10x | 0.43x | 0.88x | 0.80x | 1.07x | 0.76x | 0.67x | 1.05x | 0.47x | 0.73x | 1.08x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |